Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Atrial septal defect is a *congenital structural abnormality* of the heart in which there is a persistent opening in the atrial septum, allowing abnormal blood flow between the right and left atria. This defect increases the amount of blood circulating through the lungs, and if large or left untreated, can lead to complications such as right-sided heart enlargement, arrhythmias, pulmonary hypertension, and heart failure. ASD is diagnosed clinically and by imaging, and is treated by observation for small, asymptomatic holes or surgery/catheter closure for larger defects to prevent long-term complications[1][4][7][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atrial septal defect (ASD).